TY - JOUR
T1 - Altered phenotypic characteristics of T47D human breast cancer cells after prolonged growth in estrogen-deficient medium
AU - Fernandez, Pat
AU - Wilson, Cody
AU - Hoivik, Debie
AU - Safe, Stephen H.
N1 - Funding Information:
We wish to thank Mrs Betty Rosenbaum for excellent technical assistance with flow cytometric analyses. The financial assistance of the National Institutes of Health (CA64081) and the Texas Agricultural Experiment Station is gratefully acknowledged. S. Safe is a Sid Kyle Professor of Toxicology.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1998/9
Y1 - 1998/9
N2 - T47D human breast cancer cells were cultured in estrogen-deficient media for up to 32 months and the resulting cell line (L(hE-)) exhibited unique phenotypic and genotypic characteristics. Compared to low passage (L) cells, the L(hE-) cells exhibited a significantly higher rate of proliferation, unique morphological features, advanced ploidy status and 5- to 10-fold higher levels of the estrogen receptor (ER) as determined by ligand binding and Western blot analysis. Sequence analysis of the DNA binding domain of the ER revealed a C→A transversion which resulted in a H513N amino acid change. Treatment of L cells with 10 nM 17β-estradiol (E2) resulted in a greater than two-fold increase in cell proliferation which was inhibited by tamoxifen, 4'-hydroxytamoxifen, ICI 164,384 and ICI 182,780. In contrast, 10 nM E2 caused a 70% decrease in growth of L(hE-) cells and this antimitogenic activity was blocked by ICI 164,384 and ICI 182,780 but not by tamoxifen or 4'-hydroxytamoxifen. L(hE-) cells were E2-responsive in transient transfection studies using a plasmid containing an estrogen-responsive element derived from the vitellogenin A2 gene promoter. These data show that the phenotypic and genotypic characteristics of L(hE-) T47D cells resemble those described for ER-negative cell lines stably transfected with the ER.
AB - T47D human breast cancer cells were cultured in estrogen-deficient media for up to 32 months and the resulting cell line (L(hE-)) exhibited unique phenotypic and genotypic characteristics. Compared to low passage (L) cells, the L(hE-) cells exhibited a significantly higher rate of proliferation, unique morphological features, advanced ploidy status and 5- to 10-fold higher levels of the estrogen receptor (ER) as determined by ligand binding and Western blot analysis. Sequence analysis of the DNA binding domain of the ER revealed a C→A transversion which resulted in a H513N amino acid change. Treatment of L cells with 10 nM 17β-estradiol (E2) resulted in a greater than two-fold increase in cell proliferation which was inhibited by tamoxifen, 4'-hydroxytamoxifen, ICI 164,384 and ICI 182,780. In contrast, 10 nM E2 caused a 70% decrease in growth of L(hE-) cells and this antimitogenic activity was blocked by ICI 164,384 and ICI 182,780 but not by tamoxifen or 4'-hydroxytamoxifen. L(hE-) cells were E2-responsive in transient transfection studies using a plasmid containing an estrogen-responsive element derived from the vitellogenin A2 gene promoter. These data show that the phenotypic and genotypic characteristics of L(hE-) T47D cells resemble those described for ER-negative cell lines stably transfected with the ER.
KW - Estrogen growth-inhibition
KW - T47D variant
UR - http://www.scopus.com/inward/record.url?scp=0032157953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032157953&partnerID=8YFLogxK
U2 - 10.1006/cbir.1998.0303
DO - 10.1006/cbir.1998.0303
M3 - Article
C2 - 10452832
AN - SCOPUS:0032157953
VL - 22
SP - 623
EP - 633
JO - Cell Biology International
JF - Cell Biology International
SN - 1065-6995
IS - 9-10
ER -